Literature DB >> 14712876

Telerobotic foregut and esophageal surgery.

Jon C Gould1, W Scott Melvin.   

Abstract

Computer-assisted telerobotic surgery has many potential advantages over standard laparoscopy in foregut and esophageal surgery. The high-definition, three-dimensional images produced by the optics of these systems can facilitate identification of anatomy and dissection during surgery. The full range of motion afforded by the multiarticulated instruments can be beneficial in completing complex laparoscopic tasks such as suturing and intracorporeal knot tying. Tremor filtration and motion scaling allows for more precise movements during surgery. The remote console provides the operating surgeon with a comfortable ergonomic position during the sometimes long and complex procedures. Despite the many advantages of these systems, however, several limitations still exist. It is expected that the development and refinement of these technologies will address many of these issues. With continued progress, it is likely that this technology will disseminate widely throughout the surgical community.

Entities:  

Mesh:

Year:  2003        PMID: 14712876     DOI: 10.1016/S0039-6109(03)00160-9

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

1.  Surgical treatment of gastroesophageal reflux disease and upside-down stomach using the Da Vinci robotic system. A prospective study.

Authors:  Jens Hartmann; Christoph A Jacobi; Charalambos Menenakos; Mahmoud Ismail; Chris Braumann
Journal:  J Gastrointest Surg       Date:  2007-11-20       Impact factor: 3.452

2.  Advantages and limits of robot-assisted laparoscopic surgery: preliminary experience.

Authors:  F Corcione; C Esposito; D Cuccurullo; A Settembre; N Miranda; F Amato; F Pirozzi; P Caiazzo
Journal:  Surg Endosc       Date:  2004-11-18       Impact factor: 4.584

Review 3.  Telerobotic gastrointestinal surgery: phase 2--safety and efficacy.

Authors:  G H Ballantyne
Journal:  Surg Endosc       Date:  2007-02-08       Impact factor: 3.453

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.